Skip to main content
SpringerLink
Log in

Histopathological Assessment for Papillary Thyroid Carcinoma

  • Protocol
  • First Online:
Papillary Thyroid Carcinoma

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2534))

Abstract

Histologic assessments of papillary thyroid carcinoma are crucial for management of patients with the cancer as well as research on the cancer as papillary thyroid carcinoma has different histologic subtypes and many parameters which are essential in predicting the biological aggressiveness of the cancer. The histologic assessments should be guided by universally adopted protocols including World Health Organization (WHO) classification of endocrine tumors, International Collaboration on Cancer Reporting (ICCR) dataset, American Thyroid Association initial risk stratification for differentiated thyroid carcinomas and TNM stage groupings. The essential steps in histologic assessment involve the identification of characteristic features of papillary thyroid carcinoma, correct histologic subtyping, noting the number of carcinomas, measuring the size of the carcinoma, documenting the different aggressive histological parameters (mitotic activity, presence of tumor encapsulation/circumscription, lymphatic vessel invasion, blood vessel invasion, necrosis, extrathyroidal extension), resection margin status, associated pathology, presence of parathyroid gland, lymph node and distant metastases as well as synthesis of pathological stage based on the various clinical, macroscopic, and histological features.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Lam AK, Lo CY, Lam KS (2005) Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr Pathol 16:323–330

    Article  PubMed  Google Scholar 

  2. Lam KY, Lo CY, Chan KW, Wan KY (2000) Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231:329–338

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lam AK (2017) Pathology of endocrine tumors update: World Health Organization new classification 2017-other thyroid tumors. AJSP Rev Rep 22:209–216

    Article  Google Scholar 

  4. Ghossein R, Barletta JA, Bullock M, Johnson SJ, Kakudo K, Lam AK, Moonim MT, Poller DN, Tallini G, Tuttle RM, Xu B, Gill AJ (2021) Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol 110:62–72

    Article  PubMed  Google Scholar 

  5. Cavalheiro BG, de Matos LL, Leite AKN, Kulcsar MAV, Cernea CR, Kowalski LP (2021) Survival in differentiated thyroid carcinoma: comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system. Head Neck 43:2913–2922

    Article  PubMed  Google Scholar 

  6. Lam KY, Lui MC, Lo CY (2001) Cytokeratin expression profiles in thyroid carcinomas. Eur J Surg Oncol 27:631–635

    Article  CAS  PubMed  Google Scholar 

  7. Pakneshan S, Salajegheh A, Smith RA, Lam AK (2013) Clinicopathological relevance of BRAF mutations in human cancer. Pathology 45:346–356

    Article  CAS  PubMed  Google Scholar 

  8. Smith RA, Salajegheh A, Weinstein S, Nassiri M, Lam AK (2011) Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant. Hum Pathol 42:500–506

    Article  CAS  PubMed  Google Scholar 

  9. Salajegheh A, Petcu EB, Smith RA, Lam AK (2008) Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J 84:78–82

    Article  CAS  PubMed  Google Scholar 

  10. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JK, DeLellis RA, Harach HR, Kakudo K, LiVolsi VA, Rosai J, Sebo TJ, Sobrinho-Simoes M, Wenig BM, Lae ME (2004) Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28:1336–1340

    Article  PubMed  Google Scholar 

  11. Fu G, Polyakova O, Chazen RS, Freeman JL, Witterick IJ (2021) Diagnostic value of galectin-3 in distinguishing invasive encapsulated carcinoma from noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP). Cancers (Basel) 13:2988

    Article  CAS  Google Scholar 

  12. Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin JA, Ghossein RA (2010) Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol 23:1191–1200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Gopal PP, Montone KT, Baloch Z, Tuluc M, LiVolsi V (2011) The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma. Thyroid 21:493–499

    Article  PubMed  Google Scholar 

  14. Bronner MP, LiVolsi VA (1991) Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol 4:637–643

    CAS  PubMed  Google Scholar 

  15. Wong KS, Higgins SE, Marqusee E, Nehs MA, Angell T, Barletta JA (2019) Tall cell variant of papillary thyroid carcinoma: impact of change in WHO definition and molecular analysis. Endocr Pathol 30:43–48

    Article  CAS  PubMed  Google Scholar 

  16. Lam AK, Lo CY (2006) Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol 13:176–181

    Article  PubMed  Google Scholar 

  17. Vural Ç, Kiraz U, Turan G, Özkara SK, Sözen M, Çetinarslan B (2021) Solid variant of papillary thyroid carcinoma: an analysis of 28 cases with current literature. Ann Diagn Pathol 52:151737

    Article  PubMed  Google Scholar 

  18. Fridman M, Lam AK, Krasko O (2016) Characteristics of young adults of Belarus with post-Chernobyl papillary thyroid carcinoma: a long-term follow-up of patients with early exposure to radiation at the 30th anniversary of the accident. Clin Endocrinol 85:971–978

    Article  Google Scholar 

  19. Fridman M, Lam AK, Krasko O, Schmid KW, Branovan DI, Demidchik Y (2015) Morphological and clinical presentation of papillary thyroid carcinoma in children and adolescents of Belarus: the influence of radiation exposure and the source of irradiation. Exp Mol Pathol 98:527–531

    Article  CAS  PubMed  Google Scholar 

  20. Donaldson LB, Yan F, Morgan PF, Kaczmar JM, Fernandes JK, Nguyen SA, Jester RL, Day TA (2021) Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine 72:27–39

    Article  CAS  PubMed  Google Scholar 

  21. Janovitz T, Williamson DFK, Wong KS, Dong F, Barletta JA (2021) Genomic profile of columnar cell variant of papillary thyroid carcinoma. Histopathology 79(4):491–498. https://doi.org/10.1111/his.14374

    Article  PubMed  Google Scholar 

  22. Cunningham K, Antonetti J, Wood B (2021) Oncocytic papillary carcinoma in an autonomous thyroid nodule. Am J Case Rep 22:e931757

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lam KY, Lo CY, Wei WI (2005) Warthin tumor-like variant of papillary thyroid carcinoma: a case with dedifferentiation (anaplastic changes) and aggressive biological behavior. Endocr Pathol 16:83–89

    Article  PubMed  Google Scholar 

  24. Sahoo PK, Patnayak R, Khan PA, Jena A (2020) Warthin-like variant of papillary thyroid carcinoma-case report of an uncommon tumour with review of literature. Int J Surg Case Rep 77:9–11

    Article  PubMed  PubMed Central  Google Scholar 

  25. Juhlin CC, Höög A (2019) Clear cell variant of papillary thyroid carcinoma with associated anaplastic thyroid carcinoma: description of an extraordinary case. Int J Surg Pathol 27:658–663

    Article  PubMed  Google Scholar 

  26. Roukain A, La Rosa S, Bongiovanni M, Nicod Lalonde M, Cristina V, Montemurro M, Cochet S, Luquain A, Kopp PA, Sykiotis GP (2021) Papillary thyroid carcinoma with desmoid-type fibromatosis: review of published cases. Cancers (Basel) 13:4482

    Article  Google Scholar 

  27. Woenckhaus C, Cameselle-Teijeiro J, Ruiz-Ponte C, Abdulkader I, Reyes-Santías R, Sobrinho-Simões M (2004) Spindle cell variant of papillary thyroid carcinoma. Histopathology 45:424–427

    Article  CAS  PubMed  Google Scholar 

  28. Lam AK, Saremi N (2017) Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer. Endocr Relat Cancer 24:R109–R121

    Article  CAS  PubMed  Google Scholar 

  29. Lam AK, Fridman M (2018) Characteristics of cribriform morular variant of papillary thyroid carcinoma in post-Chernobyl affected region. Hum Pathol 74:170–177

    Article  PubMed  Google Scholar 

  30. Cameselle-Teijeiro JM, Peteiro-González D, Caneiro-Gómez J, Sánchez-Ares M, Abdulkader I, Eloy C, Melo M, Amendoeira I, Soares P, Sobrinho-Simões M (2018) Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway. Mod Pathol 31:1168–1179

    Article  CAS  PubMed  Google Scholar 

  31. Lo CY, Chan WF, Lang BH, Lam KY, Wan KY (2006) Papillary microcarcinoma: is there any difference between clinically overt and occult tumors? World J Surg 30:759–766

    Article  PubMed  Google Scholar 

  32. Lee YS, Lim H, Chang HS, Park CS (2014) Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy. J Korean Med Sci 29:676–679

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lee CR, Park S, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY, Park CS (2017) Is familial papillary thyroid microcarcinoma more aggressive than sporadic form? Ann Surg Treat Res 92:129–135

    Article  PubMed  PubMed Central  Google Scholar 

  34. Yu XM, Wan Y, Sippel RS, Chen H (2011) Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254:653–660

    Article  PubMed  Google Scholar 

  35. Aliyev E, Ladra-González MJ, Sánchez-Ares M, Abdulkader-Nallib I, Piso-Neira M, Rodríguez-Carnero G, Vieiro-Balo P, Pérez-Becerra R, Gude-Sampedro F, Barreiro-Morandeira F, Alvarez CV, Cameselle-Teijeiro JM (2020) Thyroid papillary microtumor: validation of the (updated) Porto proposal assessing sex hormone receptor expression and mutational BRAF gene status. Am J Surg Pathol 44:1161–1172

    Article  PubMed  Google Scholar 

  36. Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED (2003) Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 11:249–251

    Article  PubMed  Google Scholar 

  37. Kim KJ, Kim SG, Tan J, Shen X, Viola D, Elisei R, Puxeddu E, Fugazzola L, Colombo C, Jarzab B, Czarniecka A, Lam AK, Mian C, Vianello F, Yip L, Riesco-Eizaguirre G, Santisteban P, O’Neill CJ, Sywak MS, Clifton-Bligh R, Bendlova B, Sýkorová V, Xing M (2020) BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma. Eur J Cancer 124:161–169

    Article  CAS  PubMed  Google Scholar 

  38. Lam KY, Lo CY, Kwong DL, Lee J, Srivastava G (1999) Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus. Am J Clin Pathol 112:263–270

    Article  CAS  PubMed  Google Scholar 

  39. Abe I, Lam AK (2021) Anaplastic thyroid carcinoma: updates on WHO classification, clinicopathological features and staging. Histol Histopathol 36:239–248

    PubMed  Google Scholar 

  40. Tjahjono R, Nguyen K, Phung D, Riffat F, Palme CE (2021) Methods of identification of parathyroid glands in thyroid surgery: a literature review. ANZ J Surg 91:1711–1716

    Article  PubMed  Google Scholar 

  41. Lo CY, Lam KY (1998) Postoperative hypocalcemia in patients who did or did not undergo parathyroid autotransplantation during thyroidectomy: a comparative study. Surgery 124:1081–1086

    Article  CAS  PubMed  Google Scholar 

  42. Lo CY, Lam KY (1999) Parathyroid autotransplantation during thyroidectomy: is frozen section necessary? Arch Surg 134:258–260

    Article  CAS  PubMed  Google Scholar 

  43. Lo CY, Lam KY (2001) Routine parathyroid autotransplantation during thyroidectomy. Surgery 129:318–323

    Article  CAS  PubMed  Google Scholar 

  44. Hicks G, George R, Sywak M (2017) Short and long-term impact of parathyroid autotransplantation on parathyroid function after total thyroidectomy. Gland Surg 6(Suppl 1):S75–S85

    Article  PubMed  PubMed Central  Google Scholar 

  45. Abdullah AM, Baba HO, Salih AM, Qaradakhy AJ, Kakamad FH, Abdulla BA, Mohammed SH (2021) Co-occurrence of bilateral intrathyroidal parathyroid gland and papillary thyroid carcinoma; a case report. Int J Surg Case Rep 86:106315

    Article  PubMed  PubMed Central  Google Scholar 

  46. Alghamdi MA, Alsaif A, Altwijri AS, Alsaif FA, Alsunitan RI, Almoagal RO (2021) Synchronous incidental double parathyroid adenomas and papillary thyroid carcinoma: a case report with literature review. Niger J Clin Pract 24:954–963

    Article  CAS  PubMed  Google Scholar 

  47. Chaychi L, Belbruno K, Golding A, Memoli V (2010) Unusual manifestation of parathyroid carcinoma in the setting of papillary thyroid cancer. Endocr Pract 16:664–668

    Article  PubMed  Google Scholar 

  48. Pillai S, Gopalan V, Smith RA, Lam AK (2015) Diffuse sclerosing variant of papillary thyroid carcinoma–an update of its clinicopathological features and molecular biology. Crit Rev Oncol Hematol 94:64–73

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Molecular Pathology of School of Medicine and Dentistry, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia

    Alfred K. Lam

  2. Pathology Queensland, Gold Coast University Hospital, Southport, QLD, Australia

    Alfred K. Lam

  3. Faculty of Medicine, University of Queensland, Herston, QLD, Australia

    Alfred K. Lam

Authors
  1. Alfred K. Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfred K. Lam .

Editor information

Editors and Affiliations

  1. School of Medicine and Dentistry and Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia

    Alfred K. Lam

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Lam, A.K. (2022). Histopathological Assessment for Papillary Thyroid Carcinoma. In: Lam, A.K. (eds) Papillary Thyroid Carcinoma. Methods in Molecular Biology, vol 2534. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2505-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-2505-7_7

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-2504-0

  • Online ISBN: 978-1-0716-2505-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation